GW Pharmaceuticals Plc has raised $87.9 million in a follow-on offering of an earlier initial public offering on Nasdaq. The funds will be used to support the clinical development of a childhood epilepsy product. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
